title: [First WARFASA, now ASPIRE. The new career of ASS in long-term thromboembolism prevention].
authors.forename: Dirk
authors.initials: D
authors.lastname: Einecke
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000097:blood / Q000517:prevention & control; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D008134:Long-Term Care; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention; D013923:Thromboembolism / Q000097:blood / Q000150:complications / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D001241:Aspirin